Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States
Tiffany P Quock,1 Tingjian Yan,2 Ryan Tieu,2 Anita D’Souza,3 Michael S Broder21Medical Affairs, Prothena Biosciences Inc, South San Francisco, CA, USA; 2Health Services Research, Partnership for Health Analytic Research, LLC, Beverly Hills, CA, USA; 3Division of Hematology and Oncology, Me...
Main Authors: | Quock TP, Yan T, Tieu R, D'Souza A, Broder MS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/untangling-the-clinical-and-economic-burden-of-hospitalization-for-car-peer-reviewed-article-CEOR |
Similar Items
-
Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis
by: Suk-Chan Jang, et al.
Published: (2022-07-01) -
In-hospital mortality in amyloid light chain amyloidosis: analysis of the Premier Healthcare Database
by: Tiffany P Quock, et al.
Published: (2022-12-01) -
The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data
by: Sheila R. Reddy, et al.
Published: (2020-05-01) -
Cardiac Amyloidosis Therapy: A Systematic Review
by: Franco Iodice, et al.
Published: (2021-01-01) -
Cardiac Amyloidosis: Diagnostic Tools for a Challenging Disease
by: Marco Giuseppe Migliaccio, et al.
Published: (2021-07-01)